BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the cessation of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the cessation of a non-executive non-independent director.
BSECompany UpdateMgmt Change1 Oct 2026
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a Non-Executive Non-Independent Director.
BSECompany UpdateRegulatory1 Oct 2026
Jayant Infratech Ltd
With reference to the mail received, we hereby submitting the clarification on price movement of company''s scrip
Jayant Infratech Ltd clarifies that the recent price movement of its scrip is market-driven and not due to any specific information or event. The company has made necessary disclosures under SEBI regulations.
BSEAGM/EGMResults1 Oct 2026
Mahanagar Telephone Nigam Ltd
LETTER ATTACHED
Mahanagar Telephone Nigam Ltd has announced the voting results and scrutinizer's report of its 40th Annual General Meeting (AGM) held on September 30, 2026. The meeting was conducted through video conferencing and all the items of business were approved by the members with the requisite majority.
BSEAGM/EGM1 Oct 2026
Unified Data Tech Solutions Ltd
Scrutinizer''s Report for AGM held on 30th September,2026.
Unified Data Tech Solutions Ltd has announced the Scrutinizer's Report for its 16th Annual General Meeting held on 30th September, 2026, confirming the voting results and compliance with relevant provisions.
BSECompany UpdateMgmt Change1 Oct 2026
Cranex Ltd
Enclosed herewith is the intimation regarding the appointment of the Managing Director, Whole Time Director and Secretarial Auditor of the Company.
Cranex Ltd has announced the re-appointment of Mr. Piyush Agrawal as Managing Director and Mr. Chaitanya Agrawal as Whole-Time Director for a period of 5 years, effective from 1st October, 2026. The company has also appointed M/s. Parveen Rastogi & Co. as Secretarial Auditors for a term of 5 consecutive years.
BSECompany UpdateRating Change1 Oct 2026
ICICI Prudential Life Insurance Company Ltd
Please find enclosed intimation for credit rating by ICRA Limited.
ICICI Prudential Life Insurance Company Ltd has announced that ICRA Limited has reaffirmed the rating for its non-convertible debentures at ICRA AAA/Stable. The rating factors in the company's established market position, diversified product offering, and strong promoter profile.
BSEAGM/EGMResults1 Oct 2026
Oasis Tradelink Ltd
Voting Results/Scrutinizer Report for the 30th Annual General Meeting
Oasis Tradelink Ltd has announced the voting results for its 30th Annual General Meeting, with all resolutions passed. The company received 491 valid votes in favor of the financial statements and 19 members voted against. A director, Mr. Jigneshkumar Nareshbhai Katariya, was re-appointed with 4072 valid votes in favor.
BSEAGM/EGMMgmt Change1 Oct 2026
SC Agrotech Ltd
Voting results and Scrutinizer Report for 36th AGM of the Company
SC Agrotech Ltd has announced the voting results and scrutinizer report for its 36th AGM, with all resolutions passed with requisite majority. The company received 6,959 votes in favor of Resolution No. 1 and 6,959 votes in favor of Resolution No. 2, with 3986 votes in favor of Resolution No. 3.
BSEAGM/EGMResults1 Oct 2026
Anka India Ltd
Submission of Scrutinizer Report of 32nd Annual General Meeting of the Comapny held on 30-09-2026 through Video Conferencing.
Anka India Ltd has submitted the Scrutinizer Report of its 32nd Annual General Meeting held on September 30, 2026, through Video Conferencing. The report details the voting results for various resolutions, including the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026.